Date: 12.6.2014
Technology offer: Novel selective inhibitors applicable in viral replication, cancer and inflammation
Summary: An Italian highly innovative company with business unit in the USA, has developed a robust pipeline of novel, proprietary, selective inhibitors for a number of distinct disease indications.
The company is seeking to leverage its internal programs through licensing collaborations or technological agreements.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Cancer cells - Czech Scientists are Working to Find the Achilles‘ Heel of Cancer Cells
Biotechnology dictionary - Biotechnology, dictionary, biotech words
Reprogrammed T cells make mice (and maybe us) age slower
Synthetic antibody could be key to a universal antivenom